These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38892218)

  • 61. Effect of Lactobacillus casei Shirota supplementation on trimethylamine-N-oxide levels in patients with metabolic syndrome: An open-label, randomized study.
    Tripolt NJ; Leber B; Triebl A; Köfeler H; Stadlbauer V; Sourij H
    Atherosclerosis; 2015 Sep; 242(1):141-4. PubMed ID: 26188537
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Plasma Trimethylamine N-Oxide Levels Are Associated with Poor Kidney Function in People with Type 2 Diabetes.
    Kalagi NA; Thota RN; Stojanovski E; Alburikan KA; Garg ML
    Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839170
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Trimethylamine-N-oxide has prognostic value in coronary heart disease: a meta-analysis and dose-response analysis.
    Yao ME; Liao PD; Zhao XJ; Wang L
    BMC Cardiovasc Disord; 2020 Jan; 20(1):7. PubMed ID: 31918665
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Trimethylamine-N-oxide (TMAO) predicts fatal outcomes in community-acquired pneumonia patients without evident coronary artery disease.
    Ottiger M; Nickler M; Steuer C; Odermatt J; Huber A; Christ-Crain M; Henzen C; Hoess C; Thomann R; Zimmerli W; Mueller B; Schuetz P
    Eur J Intern Med; 2016 Dec; 36():67-73. PubMed ID: 27567042
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Trimethylamine
    Stubbs JR; Stedman MR; Liu S; Long J; Franchetti Y; West RE; Prokopienko AJ; Mahnken JD; Chertow GM; Nolin TD
    Clin J Am Soc Nephrol; 2019 Feb; 14(2):261-267. PubMed ID: 30665924
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Elevated plasma trimethylamine-N-oxide levels are associated with diabetic retinopathy.
    Liu W; Wang C; Xia Y; Xia W; Liu G; Ren C; Gu Y; Li X; Lu P
    Acta Diabetol; 2021 Feb; 58(2):221-229. PubMed ID: 33064205
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Microbiota-derived Trimethylamine N-oxide Predicts Cardiovascular Risk After STEMI.
    Matsuzawa Y; Nakahashi H; Konishi M; Sato R; Kawashima C; Kikuchi S; Akiyama E; Iwahashi N; Maejima N; Okada K; Ebina T; Hibi K; Kosuge M; Ishigami T; Tamura K; Kimura K
    Sci Rep; 2019 Aug; 9(1):11647. PubMed ID: 31406181
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Gut Microbiota-Dependent Trimethylamine N-oxide and Cardiovascular Outcomes in Patients With Prior Myocardial Infarction: A Nested Case Control Study From the PEGASUS-TIMI 54 Trial.
    Gencer B; Li XS; Gurmu Y; Bonaca MP; Morrow DA; Cohen M; Bhatt DL; Steg PG; Storey RF; Johanson P; Wang Z; Hazen SL; Sabatine MS
    J Am Heart Assoc; 2020 May; 9(10):e015331. PubMed ID: 32366163
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Impact of short-term flavanol supplementation on fasting plasma trimethylamine N-oxide concentrations in obese adults.
    Angiletta CJ; Griffin LE; Steele CN; Baer DJ; Novotny JA; Davy KP; Neilson AP
    Food Funct; 2018 Oct; 9(10):5350-5361. PubMed ID: 30264073
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Relationship of Serum Trimethylamine N-Oxide (TMAO) Levels with early Atherosclerosis in Humans.
    Randrianarisoa E; Lehn-Stefan A; Wang X; Hoene M; Peter A; Heinzmann SS; Zhao X; Königsrainer I; Königsrainer A; Balletshofer B; Machann J; Schick F; Fritsche A; Häring HU; Xu G; Lehmann R; Stefan N
    Sci Rep; 2016 May; 6():26745. PubMed ID: 27228955
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Association of plasma trimethylamine-N-oxide levels with post-stroke cognitive impairment: a 1-year longitudinal study.
    Zhu C; Li G; Lv Z; Li J; Wang X; Kang J; Zhan C
    Neurol Sci; 2020 Jan; 41(1):57-63. PubMed ID: 31420758
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Association of Trimethylamine N-Oxide and Related Metabolites in Plasma and Incident Type 2 Diabetes: The Cardiovascular Health Study.
    Lemaitre RN; Jensen PN; Wang Z; Fretts AM; McKnight B; Nemet I; Biggs ML; Sotoodehnia N; de Oliveira Otto MC; Psaty BM; Siscovick DS; Hazen SL; Mozaffarian D
    JAMA Netw Open; 2021 Aug; 4(8):e2122844. PubMed ID: 34448864
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Trimethylamine N-oxide and Risk Stratification after Acute Myocardial Infarction.
    Suzuki T; Heaney LM; Jones DJ; Ng LL
    Clin Chem; 2017 Jan; 63(1):420-428. PubMed ID: 28062632
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Trimethylamine N-oxide levels are associated with NASH in obese subjects with type 2 diabetes.
    León-Mimila P; Villamil-Ramírez H; Li XS; Shih DM; Hui ST; Ocampo-Medina E; López-Contreras B; Morán-Ramos S; Olivares-Arevalo M; Grandini-Rosales P; Macías-Kauffer L; González-González I; Hernández-Pando R; Gómez-Pérez F; Campos-Pérez F; Aguilar-Salinas C; Larrieta-Carrasco E; Villarreal-Molina T; Wang Z; Lusis AJ; Hazen SL; Huertas-Vazquez A; Canizales-Quinteros S
    Diabetes Metab; 2021 Mar; 47(2):101183. PubMed ID: 32791310
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Plasma Trimethylamine-N-oxide and impaired glucose regulation: Results from The Oral Infections, Glucose Intolerance and Insulin Resistance Study (ORIGINS).
    Roy S; Yuzefpolskaya M; Nandakumar R; Colombo PC; Demmer RT
    PLoS One; 2020; 15(1):e0227482. PubMed ID: 31940332
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Association Between Plasma Trimethylamine N-oxide and Neoatherosclerosis in Patients With Very Late Stent Thrombosis.
    Tan Y; Zhou J; Liu C; Zhou P; Sheng Z; Li J; Chen R; Song L; Zhao H; Xu B; Gao R; Yan H
    Can J Cardiol; 2020 Aug; 36(8):1252-1260. PubMed ID: 32595007
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Trimethylamine-N-oxide: A Novel Biomarker for the Identification of Inflammatory Bowel Disease.
    Wilson A; Teft WA; Morse BL; Choi YH; Woolsey S; DeGorter MK; Hegele RA; Tirona RG; Kim RB
    Dig Dis Sci; 2015 Dec; 60(12):3620-30. PubMed ID: 26160437
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Association with outcomes and response to treatment of trimethylamine N-oxide in heart failure: results from BIOSTAT-CHF.
    Suzuki T; Yazaki Y; Voors AA; Jones DJL; Chan DCS; Anker SD; Cleland JG; Dickstein K; Filippatos G; Hillege HL; Lang CC; Ponikowski P; Samani NJ; van Veldhuisen DJ; Zannad F; Zwinderman AH; Metra M; Ng LL
    Eur J Heart Fail; 2019 Jul; 21(7):877-886. PubMed ID: 30370976
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Elevation of Trimethylamine-N-Oxide in Chronic Kidney Disease: Contribution of Decreased Glomerular Filtration Rate.
    Pelletier CC; Croyal M; Ene L; Aguesse A; Billon-Crossouard S; Krempf M; Lemoine S; Guebre-Egziabher F; Juillard L; Soulage CO
    Toxins (Basel); 2019 Nov; 11(11):. PubMed ID: 31683880
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Plasma trimethylamine N-oxide (TMAO) levels predict future risk of coronary artery disease in apparently healthy individuals in the EPIC-Norfolk prospective population study.
    Tang WHW; Li XS; Wu Y; Wang Z; Khaw KT; Wareham NJ; Nieuwdorp M; Boekholdt SM; Hazen SL
    Am Heart J; 2021 Jun; 236():80-86. PubMed ID: 33626384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.